Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Omburtamab I-131 |
Trade Name | |
Synonyms | Iodine I 131 MOAB 8H9|Iodine I 131 Omburtamab |
Drug Descriptions |
Omburtamab I-131 is a radiolabeled monoclonal antibody that targets the glycoprotein B7-H3 (CD276), potentially resulting in increased tumor cell death (PMID: 30879172). |
DrugClasses | CD276 Antibody 16 |
CAS Registry Number | NA |
NCIT ID | C48400 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bevacizumab + Irinotecan + Omburtamab I-131 + Temozolomide | Bevacizumab Irinotecan Omburtamab I-131 Temozolomide | 0 | 1 |
Omburtamab I-131 | Omburtamab I-131 | 0 | 4 |